世界の全ワクチン市場予測 2020年-2025年

【英語タイトル】Global All Vaccine Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP7743)・商品コード:LPI20AP7743
・発行会社(調査会社):LP Information
・発行日:2020年3月25日(※2024年版があります。お問い合わせください)
・ページ数:159
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「全ワクチンの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌など、用途別には、大人用、子供用などに区分してまとめた調査レポートです。全ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・全ワクチンの世界市場概要(サマリー)
・全ワクチンの企業別販売量・売上
・全ワクチンの企業別市場シェア
・全ワクチンの世界市場規模 2015年-2020年:種類別(水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌)
・全ワクチンの世界市場規模 2015年-2020年:用途別(大人用、子供用)
・全ワクチンの米州市場規模(アメリカ、カナダ、メキシコなど)
・全ワクチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・全ワクチンの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・全ワクチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・全ワクチン市場の成長要因・課題・動向
・全ワクチンの世界市場予測 2021年-2025年
・全ワクチンの米州市場予測(アメリカ、カナダ、メキシコなど)
・全ワクチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・全ワクチンの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・全ワクチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・全ワクチンの世界市場予測:種類別(水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌)
・全ワクチンの世界市場予測:用途別(大人用、子供用)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the All Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in All Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of All Vaccine market by type, application, key manufacturers and key regions and countries.

This study considers the All Vaccine value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
For Adult
For Child

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CNBG
Novartis
ChengDa Bio
Zhifei
SINOVAC BIOTECH
Changsheng Life
Kangtai
NuoCheng Bio
SANOFI PASTEUR
Hualan Bio
GSK

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global All Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of All Vaccine market by identifying its various subsegments.
Focuses on the key global All Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the All Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of All Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global All Vaccine Consumption 2015-2025
2.1.2 All Vaccine Consumption CAGR by Region
2.2 All Vaccine Segment by Type
2.2.1 Varicella
2.2.2 Influenza
2.2.3 Polio
2.2.4 Hepatitis A
2.2.5 Rabies
2.2.6 BCG
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, tetanus
2.2.9 Pneumococcal
2.2.10 Others
2.3 All Vaccine Consumption by Type
2.3.1 Global All Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global All Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global All Vaccine Sale Price by Type (2015-2020)
2.4 All Vaccine Segment by Application
2.4.1 For Adult
2.4.2 For Child
2.5 All Vaccine Consumption by Application
2.5.1 Global All Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global All Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global All Vaccine Sale Price by Type (2015-2020)

3 Global All Vaccine by Company
3.1 Global All Vaccine Sales Market Share by Company
3.1.1 Global All Vaccine Sales by Company (2018-2020)
3.1.2 Global All Vaccine Sales Market Share by Company (2018-2020)
3.2 Global All Vaccine Revenue Market Share by Company
3.2.1 Global All Vaccine Revenue by Company (2018-2020)
3.2.2 Global All Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global All Vaccine Sale Price by Company
3.4 Global All Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global All Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players All Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 All Vaccine by Regions
4.1 All Vaccine by Regions
4.2 Americas All Vaccine Consumption Growth
4.3 APAC All Vaccine Consumption Growth
4.4 Europe All Vaccine Consumption Growth
4.5 Middle East & Africa All Vaccine Consumption Growth

5 Americas
5.1 Americas All Vaccine Consumption by Countries
5.1.1 Americas All Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas All Vaccine Value by Countries (2015-2020)
5.2 Americas All Vaccine Consumption by Type
5.3 Americas All Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC All Vaccine Consumption by Regions
6.1.1 APAC All Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC All Vaccine Value by Regions (2015-2020)
6.2 APAC All Vaccine Consumption by Type
6.3 APAC All Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe All Vaccine by Countries
7.1.1 Europe All Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe All Vaccine Value by Countries (2015-2020)
7.2 Europe All Vaccine Consumption by Type
7.3 Europe All Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa All Vaccine by Countries
8.1.1 Middle East & Africa All Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa All Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa All Vaccine Consumption by Type
8.3 Middle East & Africa All Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 All Vaccine Distributors
10.3 All Vaccine Customer

11 Global All Vaccine Market Forecast
11.1 Global All Vaccine Consumption Forecast (2021-2025)
11.2 Global All Vaccine Forecast by Regions
11.2.1 Global All Vaccine Forecast by Regions (2021-2025)
11.2.2 Global All Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global All Vaccine Forecast by Type
11.8 Global All Vaccine Forecast by Application

12 Key Players Analysis
12.1 CNBG
12.1.1 Company Information
12.1.2 All Vaccine Product Offered
12.1.3 CNBG All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CNBG Latest Developments
12.2 Novartis
12.2.1 Company Information
12.2.2 All Vaccine Product Offered
12.2.3 Novartis All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Novartis Latest Developments
12.3 ChengDa Bio
12.3.1 Company Information
12.3.2 All Vaccine Product Offered
12.3.3 ChengDa Bio All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 ChengDa Bio Latest Developments
12.4 Zhifei
12.4.1 Company Information
12.4.2 All Vaccine Product Offered
12.4.3 Zhifei All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Zhifei Latest Developments
12.5 SINOVAC BIOTECH
12.5.1 Company Information
12.5.2 All Vaccine Product Offered
12.5.3 SINOVAC BIOTECH All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 SINOVAC BIOTECH Latest Developments
12.6 Changsheng Life
12.6.1 Company Information
12.6.2 All Vaccine Product Offered
12.6.3 Changsheng Life All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Changsheng Life Latest Developments
12.7 Kangtai
12.7.1 Company Information
12.7.2 All Vaccine Product Offered
12.7.3 Kangtai All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Kangtai Latest Developments
12.8 NuoCheng Bio
12.8.1 Company Information
12.8.2 All Vaccine Product Offered
12.8.3 NuoCheng Bio All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 NuoCheng Bio Latest Developments
12.9 SANOFI PASTEUR
12.9.1 Company Information
12.9.2 All Vaccine Product Offered
12.9.3 SANOFI PASTEUR All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 SANOFI PASTEUR Latest Developments
12.10 Hualan Bio
12.10.1 Company Information
12.10.2 All Vaccine Product Offered
12.10.3 Hualan Bio All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hualan Bio Latest Developments
12.11 GSK
12.11.1 Company Information
12.11.2 All Vaccine Product Offered
12.11.3 GSK All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 GSK Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. All Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Varicella
Table 5. Major Players of Influenza
Table 6. Major Players of Polio
Table 7. Major Players of Hepatitis A
Table 8. Major Players of Rabies
Table 9. Major Players of BCG
Table 10. Major Players of Hepatitis B
Table 11. Major Players of Pertussis, Diphtheria, tetanus
Table 12. Major Players of Pneumococcal
Table 13. Major Players of Others
Table 14. Global Consumption Sales by Type (2015-2020)
Table 15. Global All Vaccine Consumption Market Share by Type (2015-2020)
Table 16. Global All Vaccine Revenue by Type (2015-2020) ($ million)
Table 17. Global All Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 18. Global All Vaccine Sale Price by Type (2015-2020)
Table 19. Global Consumption Sales by Application (2015-2020)
Table 20. Global All Vaccine Consumption Market Share by Application (2015-2020)
Table 21. Global All Vaccine Value by Application (2015-2020)
Table 22. Global All Vaccine Value Market Share by Application (2015-2020)
Table 23. Global All Vaccine Sale Price by Application (2015-2020)
Table 24. Global All Vaccine Sales by Company (2017-2019) (M Dose)
Table 25. Global All Vaccine Sales Market Share by Company (2017-2019)
Table 26. Global All Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 27. Global All Vaccine Revenue Market Share by Company (2017-2019)
Table 28. Global All Vaccine Sale Price by Company (2017-2019)
Table 29. Global All Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 30. Players All Vaccine Products Offered
Table 31. All Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 32. Global All Vaccine Consumption by Regions 2015-2020 (M Dose)
Table 33. Global All Vaccine Consumption Market Share by Regions 2015-2020
Table 34. Global All Vaccine Value by Regions 2015-2020 ($ Millions)
Table 35. Global All Vaccine Value Market Share by Regions 2015-2020
Table 36. Americas All Vaccine Consumption by Countries (2015-2020) (M Dose)
Table 37. Americas All Vaccine Consumption Market Share by Countries (2015-2020)
Table 38. Americas All Vaccine Value by Countries (2015-2020) ($ Millions)
Table 39. Americas All Vaccine Value Market Share by Countries (2015-2020)
Table 40. Americas All Vaccine Consumption by Type (2015-2020) (M Dose)
Table 41. Americas All Vaccine Consumption Market Share by Type (2015-2020)
Table 42. Americas All Vaccine Consumption by Application (2015-2020) (M Dose)
Table 43. Americas All Vaccine Consumption Market Share by Application (2015-2020)
Table 44. APAC All Vaccine Consumption by Countries (2015-2020) (M Dose)
Table 45. APAC All Vaccine Consumption Market Share by Countries (2015-2020)
Table 46. APAC All Vaccine Value by Regions (2015-2020) ($ Millions)
Table 47. APAC All Vaccine Value Market Share by Regions (2015-2020)
Table 48. APAC All Vaccine Consumption by Type (2015-2020) (M Dose)
Table 49. APAC All Vaccine Consumption Market Share by Type (2015-2020)
Table 50. APAC All Vaccine Consumption by Application (2015-2020) (M Dose)
Table 51. APAC All Vaccine Consumption Market Share by Application (2015-2020)
Table 52. Europe All Vaccine Consumption by Countries (2015-2020) (M Dose)
Table 53. Europe All Vaccine Consumption Market Share by Countries (2015-2020)
Table 54. Europe All Vaccine Value by Countries (2015-2020) ($ Millions)
Table 55. Europe All Vaccine Value Market Share by Countries (2015-2020)
Table 56. Europe All Vaccine Consumption by Type (2015-2020) (M Dose)
Table 57. Europe All Vaccine Consumption Market Share by Type (2015-2020)
Table 58. Europe All Vaccine Consumption by Application (2015-2020) (M Dose)
Table 59. Europe All Vaccine Consumption Market Share by Application (2015-2020)
Table 60. Middle East & Africa All Vaccine Consumption by Countries (2015-2020) (M Dose)
Table 61. Middle East & Africa All Vaccine Consumption Market Share by Countries (2015-2020)
Table 62. Middle East & Africa All Vaccine Value by Countries (2015-2020) ($ Millions)
Table 63. Middle East & Africa All Vaccine Value Market Share by Countries (2015-2020)
Table 64. Middle East & Africa All Vaccine Consumption by Type (2015-2020) (M Dose)
Table 65. Middle East & Africa All Vaccine Consumption Market Share by Type (2015-2020)
Table 66. Middle East & Africa All Vaccine Consumption by Application (2015-2020) (M Dose)
Table 67. Middle East & Africa All Vaccine Consumption Market Share by Application (2015-2020)
Table 68. All Vaccine Distributors List
Table 69. All Vaccine Customer List
Table 70. Global All Vaccine Consumption Forecast by Countries (2021-2025) (M Dose)
Table 71. Global All Vaccine Consumption Market Forecast by Regions
Table 72. Global All Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 73. Global All Vaccine Value Market Share Forecast by Regions
Table 74. Global All Vaccine Consumption Forecast by Type (2021-2025) (M Dose)
Table 75. Global All Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 76. Global All Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 77. Global All Vaccine Value Market Share Forecast by Type (2021-2025)
Table 78. Global All Vaccine Consumption Forecast by Application (2021-2025) (M Dose)
Table 79. Global All Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 80. Global All Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 81. Global All Vaccine Value Market Share Forecast by Application (2021-2025)
Table 82. CNBG Product Offered
Table 83. CNBG All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 84. CNBG Main Business
Table 85. CNBG Latest Developments
Table 86. CNBG Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Novartis Product Offered
Table 88. Novartis All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 89. Novartis Main Business
Table 90. Novartis Latest Developments
Table 91. Novartis Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. ChengDa Bio Product Offered
Table 93. ChengDa Bio All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 94. ChengDa Bio Main Business
Table 95. ChengDa Bio Latest Developments
Table 96. ChengDa Bio Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. Zhifei Product Offered
Table 98. Zhifei All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 99. Zhifei Main Business
Table 100. Zhifei Latest Developments
Table 101. Zhifei Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. SINOVAC BIOTECH Product Offered
Table 103. SINOVAC BIOTECH All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 104. SINOVAC BIOTECH Main Business
Table 105. SINOVAC BIOTECH Latest Developments
Table 106. SINOVAC BIOTECH Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. Changsheng Life Product Offered
Table 108. Changsheng Life All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 109. Changsheng Life Main Business
Table 110. Changsheng Life Latest Developments
Table 111. Changsheng Life Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. Kangtai Product Offered
Table 113. Kangtai Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Kangtai Main Business
Table 115. Kangtai Latest Developments
Table 116. Kangtai All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 117. NuoCheng Bio Product Offered
Table 118. NuoCheng Bio All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 119. NuoCheng Bio Main Business
Table 120. NuoCheng Bio Latest Developments
Table 121. NuoCheng Bio Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. SANOFI PASTEUR Product Offered
Table 123. SANOFI PASTEUR All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 124. SANOFI PASTEUR Main Business
Table 125. SANOFI PASTEUR Latest Developments
Table 126. SANOFI PASTEUR Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. Hualan Bio Product Offered
Table 128. Hualan Bio All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 129. Hualan Bio Main Business
Table 130. Hualan Bio Latest Developments
Table 131. Hualan Bio Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. GSK Product Offered
Table 133. GSK All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 134. GSK Main Business
Table 135. GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. GSK Latest Developments
List of Figures
Figure 1. Picture of All Vaccine
Figure 2. All Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global All Vaccine Consumption Growth Rate 2015-2025 (M Dose)
Figure 5. Global All Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Varicella
Figure 7. Product Picture of Influenza
Figure 8. Product Picture of Polio
Figure 9. Product Picture of Hepatitis A
Figure 10. Product Picture of Rabies
Figure 11. Product Picture of BCG
Figure 12. Product Picture of Hepatitis B
Figure 13. Product Picture of Pertussis, Diphtheria, tetanus
Figure 14. Product Picture of Pneumococcal
Figure 15. Product Picture of Others
Figure 16. Global All Vaccine Consumption Market Share by Type (2015-2020)
Figure 17. Global All Vaccine Value Market Share by Type (2015-2020)
Figure 18. All Vaccine Consumed in For Adult
Figure 19. Global All Vaccine Market: For Adult (2015-2020) (M Dose)
Figure 20. Global All Vaccine Market: For Adult (2015-2020) ($ Millions)
Figure 21. All Vaccine Consumed in For Child
Figure 22. Global All Vaccine Market: For Child (2015-2020) (M Dose)
Figure 23. Global All Vaccine Market: For Child (2015-2020) ($ Millions)
Figure 24. Global All Vaccine Consumption Market Share by Application (2015-2020)
Figure 25. Global All Vaccine Value Market Share by Application (2015-2020)
Figure 26. Global All Vaccine Sales Market Share by Company in 2017
Figure 27. Global All Vaccine Sales Market Share by Company in 2019
Figure 28. Global All Vaccine Revenue Market Share by Company in 2017
Figure 29. Global All Vaccine Revenue Market Share by Company in 2019
Figure 30. Global All Vaccine Sale Price by Company in 2019
Figure 31. Global All Vaccine Consumption Market Share by Regions 2015-2020
Figure 32. Global All Vaccine Value Market Share by Regions 2015-2020
Figure 33. Americas All Vaccine Consumption 2015-2020 (M Dose)
Figure 34. Americas All Vaccine Value 2015-2020 ($ Millions)
Figure 35. APAC All Vaccine Consumption 2015-2020 (M Dose)
Figure 36. APAC All Vaccine Value 2015-2020 ($ Millions)
Figure 37. Europe All Vaccine Consumption 2015-2020 (M Dose)
Figure 38. Europe All Vaccine Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa All Vaccine Consumption 2015-2020 (M Dose)
Figure 40. Middle East & Africa All Vaccine Value 2015-2020 ($ Millions)
Figure 41. Americas All Vaccine Consumption Market Share by Countries in 2019
Figure 42. Americas All Vaccine Value Market Share by Countries in 2019
Figure 43. Americas All Vaccine Consumption Market Share by Type in 2019
Figure 44. Americas All Vaccine Consumption Market Share by Application in 2019
Figure 45. United States All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 46. United States All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 47. Canada All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 48. Canada All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 50. Mexico All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 51. APAC All Vaccine Consumption Market Share by Countries in 2019
Figure 52. APAC All Vaccine Value Market Share by Regions in 2019
Figure 53. APAC All Vaccine Consumption Market Share by Type in 2019
Figure 54. APAC All Vaccine Consumption Market Share by Application in 2019
Figure 55. China All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 56. China All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 57. Japan All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 58. Japan All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 59. Korea All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 60. Korea All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 62. Southeast Asia All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 63. India All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 64. India All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 65. Australia All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 66. Australia All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 67. Europe All Vaccine Consumption Market Share by Countries in 2019
Figure 68. Europe All Vaccine Value Market Share by Countries in 2019
Figure 69. Europe All Vaccine Consumption Market Share by Type in 2019
Figure 70. Europe All Vaccine Consumption Market Share by Application in 2019
Figure 71. Germany All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 72. Germany All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 73. France All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 74. France All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 75. UK All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 76. UK All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 77. Italy All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 78. Italy All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 79. Russia All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 80. Russia All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 81. Spain All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 82. Spain All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 83. Middle East & Africa All Vaccine Consumption Market Share by Countries in 2019
Figure 84. Middle East & Africa All Vaccine Value Market Share by Countries in 2019
Figure 85. Middle East & Africa All Vaccine Consumption Market Share by Type in 2019
Figure 86. Middle East & Africa All Vaccine Consumption Market Share by Application in 2019
Figure 87. Egypt All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 88. Egypt All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 89. South Africa All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 90. South Africa All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 91. Israel All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 92. Israel All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 93. Turkey All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 94. Turkey All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 95. GCC Countries All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 96. GCC Countries All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 97. Global All Vaccine Consumption Growth Rate Forecast (2021-2025) (M Dose)
Figure 98. Global All Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 99. Americas All Vaccine Consumption 2021-2025 (M Dose)
Figure 100. Americas All Vaccine Value 2021-2025 ($ Millions)
Figure 101. APAC All Vaccine Consumption 2021-2025 (M Dose)
Figure 102. APAC All Vaccine Value 2021-2025 ($ Millions)
Figure 103. Europe All Vaccine Consumption 2021-2025 (M Dose)
Figure 104. Europe All Vaccine Value 2021-2025 ($ Millions)
Figure 105. Middle East & Africa All Vaccine Consumption 2021-2025 (M Dose)
Figure 106. Middle East & Africa All Vaccine Value 2021-2025 ($ Millions)
Figure 107. United States All Vaccine Consumption 2021-2025 (M Dose)
Figure 108. United States All Vaccine Value 2021-2025 ($ Millions)
Figure 109. Canada All Vaccine Consumption 2021-2025 (M Dose)
Figure 110. Canada All Vaccine Value 2021-2025 ($ Millions)
Figure 111. Mexico All Vaccine Consumption 2021-2025 (M Dose)
Figure 112. Mexico All Vaccine Value 2021-2025 ($ Millions)
Figure 113. Brazil All Vaccine Consumption 2021-2025 (M Dose)
Figure 114. Brazil All Vaccine Value 2021-2025 ($ Millions)
Figure 115. China All Vaccine Consumption 2021-2025 (M Dose)
Figure 116. China All Vaccine Value 2021-2025 ($ Millions)
Figure 117. Japan All Vaccine Consumption 2021-2025 (M Dose)
Figure 118. Japan All Vaccine Value 2021-2025 ($ Millions)
Figure 119. Korea All Vaccine Consumption 2021-2025 (M Dose)
Figure 120. Korea All Vaccine Value 2021-2025 ($ Millions)
Figure 121. Southeast Asia All Vaccine Consumption 2021-2025 (M Dose)
Figure 122. Southeast Asia All Vaccine Value 2021-2025 ($ Millions)
Figure 123. India All Vaccine Consumption 2021-2025 (M Dose)
Figure 124. India All Vaccine Value 2021-2025 ($ Millions)
Figure 125. Australia All Vaccine Consumption 2021-2025 (M Dose)
Figure 126. Australia All Vaccine Value 2021-2025 ($ Millions)
Figure 127. Germany All Vaccine Consumption 2021-2025 (M Dose)
Figure 128. Germany All Vaccine Value 2021-2025 ($ Millions)
Figure 129. France All Vaccine Consumption 2021-2025 (M Dose)
Figure 130. France All Vaccine Value 2021-2025 ($ Millions)
Figure 131. UK All Vaccine Consumption 2021-2025 (M Dose)
Figure 132. UK All Vaccine Value 2021-2025 ($ Millions)
Figure 133. Italy All Vaccine Consumption 2021-2025 (M Dose)
Figure 134. Italy All Vaccine Value 2021-2025 ($ Millions)
Figure 135. Russia All Vaccine Consumption 2021-2025 (M Dose)
Figure 136. Russia All Vaccine Value 2021-2025 ($ Millions)
Figure 137. Spain All Vaccine Consumption 2021-2025 (M Dose)
Figure 138. Spain All Vaccine Value 2021-2025 ($ Millions)
Figure 139. Egypt All Vaccine Consumption 2021-2025 (M Dose)
Figure 140. Egypt All Vaccine Value 2021-2025 ($ Millions)
Figure 141. South Africa All Vaccine Consumption 2021-2025 (M Dose)
Figure 142. South Africa All Vaccine Value 2021-2025 ($ Millions)
Figure 143. Israel All Vaccine Consumption 2021-2025 (M Dose)
Figure 144. Israel All Vaccine Value 2021-2025 ($ Millions)
Figure 145. Turkey All Vaccine Consumption 2021-2025 (M Dose)
Figure 146. Turkey All Vaccine Value 2021-2025 ($ Millions)
Figure 147. GCC Countries All Vaccine Consumption 2021-2025 (M Dose)
Figure 148. GCC Countries All Vaccine Value 2021-2025 ($ Millions)
Figure 149. CNBG All Vaccine Market Share (2018-2020)
Figure 150. Novartis All Vaccine Market Share (2018-2020)
Figure 151. ChengDa Bio All Vaccine Market Share (2018-2020)
Figure 152. Zhifei All Vaccine Market Share (2018-2020)
Figure 153. SINOVAC BIOTECH All Vaccine Market Share (2018-2020)
Figure 154. Changsheng Life All Vaccine Market Share (2018-2020)
Figure 155. Kangtai All Vaccine Market Share (2018-2020)
Figure 156. NuoCheng Bio All Vaccine Market Share (2018-2020)
Figure 157. SANOFI PASTEUR All Vaccine Market Share (2018-2020)
Figure 158. Hualan Bio All Vaccine Market Share (2018-2020)
Figure 159. GSK All Vaccine Market Share (2018-2020)


★調査レポート[世界の全ワクチン市場予測 2020年-2025年] (コード:LPI20AP7743)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の全ワクチン市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆